Heartflow
Turns coronary CT scans into anatomy, blood-flow, plaque, and procedure-planning analyses.
$47.78
After-hours close0.00 (0.00%)
At close$47.78(−0.67%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 88.50%76.32M sharesInsiders 2.88%2.49M sharesOther 8.62%7.43M shares
Shares outstanding 86.24M · Float 66.29M · 76.9% free float
Institutions13F, as of Jun 30, 2026
199 holders · 76.32M shares · 53 new positions · 143 increased · 38 reduced · 26 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8.45M | 9.80% | −2.00M | Aug 14, 2026 |
| Wellington Management Group LLP | 7.86M | 9.12% | −4.12M | Aug 14, 2026 |
| BlackRock, Inc. | 5.20M | 6.03% | +3.74M | Aug 7, 2026 |
| FMR LLC | 4.82M | 5.59% | −576.9K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 3.58M | 4.16% | +1.54M | Aug 13, 2026 |
| Bamco Inc /NY/ | 3.23M | 3.74% | −602.4K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 2.75M | 3.19% | +859.7K | Aug 13, 2026 |
| Jupiter Topco LLC | 2.42M | 2.81% | +2.42Mnew | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Wellington Management Group LLP | 14.00% | 11.92M | 13G | Mar 5, 2026 ↗ |
| BCLS Fund III Investments, LP | 12.18% | 10.45M | 13G | May 15, 2026 ↗ |
| BlackRock, Inc. | 5.70% | 4.93M | 13G | Jul 28, 2026 ↗ |
| FMR LLC | 5.70% | 4.73M | 13G | Nov 5, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 10 percent owner | 8.45M | 9.80% | Apr 30, 2026 |
| Jeffrey C. Lightcap | director | 1.13M | 1.31% | Jul 28, 2026 |
| John C.M. Farquhar | director, officer: Chief Executive Officer | 360.8K | 0.42% | Aug 25, 2026 |
| Vikram Verghese | officer: Chief Financial Officer | 254.6K | 0.30% | Aug 10, 2026 |
| William C. Weldon | director | 243.9K | 0.28% | Jul 10, 2026 |
| Timothy C. Barabe | director | 188.2K | 0.22% | Jul 24, 2026 |
| Campbell Rogers | officer: Chief Medical Officer | 137.2K | 0.16% | Aug 19, 2026 |
| Casey M. Tansey | director | 114.8K | 0.13% | Aug 11, 2025 |
| Marie L. Jones | officer: Chief Accounting Officer | 32.2K | 0.04% | Aug 10, 2026 |
| Julie A. Cullivan | director | 27.3K | 0.03% | Mar 6, 2026 |
1 ten-percent owner holds 8.45M shares by Form 4, outside the officers-and-directors figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 21, 2026 | John C.M. Farquhardirector, officer: Chief Executive Officer | Sale | 27,230 | $50.00 | 360,814 |
| Aug 18, 2026 | John C.M. Farquhardirector, officer: Chief Executive Officer | Sale | 32,676 | $45.00 | 388,044 |
| Aug 17, 2026 | Campbell Rogersofficer: Chief Medical Officer | Sale | 9,219 | $41.23 | 86,459 |
| Aug 14, 2026 | John C.M. Farquhardirector, officer: Chief Executive Officer | Sale | 15,560 | $39.06 | 420,720 |
| Aug 10, 2026 | John C.M. Farquhardirector, officer: Chief Executive Officer | Sale | 22,562 | $28.31 | 436,280 |
| Jul 15, 2026 | Campbell Rogersofficer: Chief Medical Officer | Sale | 9,219 | $25.72 | 88,731 |
| Jul 10, 2026 | John C.M. Farquhardirector, officer: Chief Executive Officer | Sale | 22,562 | $27.75 | 435,373 |
| Jun 24, 2026 | John C.M. Farquhardirector, officer: Chief Executive Officer | Sale | 38,900 | $35.00 | 457,935 |
| Jun 10, 2026 | John C.M. Farquhardirector, officer: Chief Executive Officer | Sale | 22,562 | $28.50 | 496,835 |
| May 18, 2026 | Campbell Rogersofficer: Chief Medical Officer | Sale | 9,219 | $28.34 | 78,731 |
CongressHouse and Senate disclosures
Not reported.